Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from Staphylococcal protein A

被引:52
作者
Henning, P
Magnusson, MK
Gunneriusson, E
Hong, SS
Boulanger, P
Nygren, PÅ
Lindholm, L [1 ]
机构
[1] Got A Gene AB, Stena Ctr 1B, SE-41292 Gothenburg, Sweden
[2] Univ Gothenburg, Dept Med Microbiol & Immunol, SE-40530 Gothenburg, Sweden
[3] Affibody AB, SE-16102 Bromma, Sweden
[4] Fac Med RTH Laennec, Lab Virol & Pathogenese Virale, F-69372 Lyon 08, France
[5] Royal Inst Technol, Dept Biotechnol, SE-10691 Stockholm, Sweden
关键词
D O I
10.1089/10430340260185067
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The use of adenovirus (Ad) as an efficient and versatile vector for in vivo tumor therapy requires the modulation of its cellular tropism. We previously developed a method to genetically alter the tropism of Ad5 fibers by replacing the fiber knob domain by an extrinsic trimerization motif and a new cellular ligand. However, fibers carrying complex ligands such as single-chain antibody fragments did not assemble into functional pentons in vitro in the presence of penton base, and failed to be rescued into infectious virions because of their inability to fold correctly within the cytoplasm of Ad-infected cells. Here we show that the coding sequence for a disulfide bond-independent three-helix bundle scaffold Z, derived from domain B of Staphylococcal protein A and capable of binding to the Fc portion of immunoglobulin (Ig) G1, could be incorporated into modified knobless Ad fiber gene constructs with seven shaft repeats. These fiber gene constructs could be rescued into viable virions that were demonstrated to enter 293 cells engineered for IgG Fc surface expression but not unmodified 293 cells, via a mechanism that could be specifically blocked with soluble Fc target protein. However, the tropism modified viruses showed a slightly impaired cellular entry and a lower infectivity than wildtype (WT) virus. In addition, we generated recombinant fibers containing an IgA binding Affibody(TM) ligand, derived from combinatorial specificity-engineering of the Z domain scaffold. Such fiber constructs also showed the expected target specific binding, indicating that the affibody protein class is ideally suited for genetic engineering of Ad tropism.
引用
收藏
页码:1427 / 1439
页数:13
相关论文
共 39 条
[1]   Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 [J].
Bergelson, JM ;
Cunningham, JA ;
Droguett, G ;
KurtJones, EA ;
Krithivas, A ;
Hong, JS ;
Horwitz, MS ;
Crowell, RL ;
Finberg, RW .
SCIENCE, 1997, 275 (5304) :1320-1323
[2]   Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR [J].
Bewley, MC ;
Springer, K ;
Zhang, YB ;
Freimuth, P ;
Flanagan, JM .
SCIENCE, 1999, 286 (5444) :1579-1583
[3]   REDOX STATE OF SINGLE-CHAIN FV FRAGMENTS TARGETED TO THE ENDOPLASMIC-RETICULUM, CYTOSOL AND MITOCHONDRIA [J].
BIOCCA, S ;
RUBERTI, F ;
TAFANI, M ;
PIERANDREIAMALDI, P ;
CATTANEO, A .
BIO-TECHNOLOGY, 1995, 13 (10) :1110-1115
[4]  
Chroboczek J, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P163
[5]  
CLACKSON T, 1991, PCR PRACTICAL APPROA, P187
[6]   An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism [J].
Dmitriev, I ;
Krasnykh, V ;
Miller, CR ;
Wang, MH ;
Kashentseva, E ;
Mikheeva, G ;
Belousova, N ;
Curiel, DT .
JOURNAL OF VIROLOGY, 1998, 72 (12) :9706-9713
[7]  
Gunneriusson E, 1999, APPL ENVIRON MICROB, V65, P4134
[8]   Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM [J].
Haisma, HJ ;
Pinedo, HM ;
van Rijswijk, A ;
van der Muelen-Muileman, I ;
Sosnowski, BA ;
Ying, W ;
van Beusechem, VW ;
Tillman, BW ;
Gerritsen, WR ;
Curiel, DT .
GENE THERAPY, 1999, 6 (08) :1469-1474
[9]   An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein [J].
Hansson, M ;
Ringdahl, J ;
Robert, A ;
Power, U ;
Goetsch, L ;
Nguyen, TN ;
Uhlén, M ;
Ståhl, S ;
Nygren, PÅ .
IMMUNOTECHNOLOGY, 1999, 4 (3-4) :237-252
[10]  
HONG JS, 1991, VIROLOGY, V185, P758